ScholarIQanswers from OpenAlex
Q Therapeutics (United States)
InstitutionResearch output, impact & collaborations
Q Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Q Therapeutics (United States)?
ScholarIQrecord summary
Q Therapeutics (United States) is a research organisation in Salt Lake City, US. OpenAlex records 345 works and 17,772 citations for it. 279 researchers list it as their most recent affiliation.
How many works does Q Therapeutics (United States) have?
ScholarIQindexed works
Q Therapeutics (United States) has 345 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Q Therapeutics (United States) have?
ScholarIQcitation count
Q Therapeutics (United States) has 17,772 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Q Therapeutics (United States)?
ScholarIQresearcher count
Q Therapeutics (United States) has 279 researchers in the ScholarIQ index.
What is the average h-index at Q Therapeutics (United States)?
ScholarIQavg h-index
Q Therapeutics (United States) has an average h-index of 46.5 in OpenAlex.
What is the ROR of Q Therapeutics (United States)?
ScholarIQror
The ROR for Q Therapeutics (United States) is on the source record.
What is the OpenAlex record for Q Therapeutics (United States)?
ScholarIQopenalex
The OpenAlex for Q Therapeutics (United States) is on the source record.
Who are the most-cited researchers behind Q Therapeutics (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Q Therapeutics (United States)?
ScholarIQmost cited works
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, K. Venkatesan, Adam A. Margolin, Sung Joon Kim, Christopher J. Wilson, Joseph Lehár, Gregory V. Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F. Berger, John E. Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané‐Valbuena, Felipa Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H. Engels, Jill Cheng, Guoying Karen Yu, Jianjun Yu, Peter Aspesi, Melanie de Silva, Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky, Ann Marie Egloff, Aaron D. Tward, Aleksandar D. Kostic, Kristian Cibulskis, Andrey Sivachenko, Gregory V. Kryukov, Michael S. Lawrence, Carrie Sougnez, Aaron McKenna, Erica Shefler, Alex H. Ramos, Petar Stojanov, Scott L. Carter, Douglas Voet, Maria L. Cortés, Daniel Auclair, Michael F. Berger, Gordon Saksena, Candace Guiducci, Robert C. Onofrio, Melissa Parkin, Marjorie Romkes, Joel L. Weissfeld, Raja R. Seethala, Lin Wang, Claudia Rangel‐Escareño, Juan Carlos Fernández-López, Alfredo Hidalgo‐Miranda, Jorge Meléndez-Zajgla, Wendy Winckler, Kristin Ardlie, Stacey Gabriel, Matthew Meyerson, Eric S. Lander, Gad Getz, Todd R. Golub, Levi A. Garraway, Jennifer R. Grandis
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald, María Gomez‐Caraballo, Faria M. Siddiqui, Hillary E. Mulvey, Yosef E. Maruvka, Fei Ji, Hyo-Eun Carrie Bhang, Viveksagar Krishnamurthy Radhakrishna, Giulia Siravegna, Haichuan Hu, Sana Raoof, Elizabeth L. Lockerman, Anuj Kalsy, Dana Lee, Celina L Keating, David A. Ruddy, Leah J. Damon, Adam Crystal, Carlotta Costa, Zofia Piotrowska, Alberto Bardelli, A. John Iafrate, Ruslan I. Sadreyev, Frank Stegmeier, Gad Getz, Lecia V. Sequist, Anthony C. Faber, Jeffrey A. Engelman
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
Eliezer M. Van Allen, Nikhil Wagle, Petar Stojanov, Danielle Perrin, Kristian Cibulskis, Sara Marlow, Judit Jané‐Valbuena, Dennis C. Friedrich, Gregory V. Kryukov, Scott L. Carter, Aaron McKenna, Andrey Sivachenko, Mara Rosenberg, Adam Kieżun, Douglas Voet, Michael S. Lawrence, Lee Lichtenstein, Jeff Gentry, Franklin W. Huang, Jennifer Fostel, Deborah Farlow, David A. Barbie, Leena Gandhi, Eric S. Lander, Stacy W. Gray, Steven Joffe, Pasi A. Jänne, Judy E. Garber, Laura E. MacConaill, Neal I. Lindeman, Barrett J. Rollins, Philip W. Kantoff, Sheila Fisher, Stacey Gabriel, Gad Getz, Levi A. Garraway
How much of the research on Q Therapeutics (United States) is open access?
ScholarIQopen access share
75%OPEN ACCESS